$CHRS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Coherus BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Coherus BioSciences, Inc.. Get notifications about new insider transactions in Coherus BioSciences, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 25 2021 | CHRS | Coherus BioScience ... | STOLPER MARK | Director | Option Exercise | A | 13.48 | 20,000 | 269,600 | 20,000 | |
Apr 30 2021 | CHRS | Coherus BioScience ... | Stilwell McDavid | Chief Financial Off ... | Option Exercise | A | 14.76 | 50,000 | 738,000 | 50,000 | |
Apr 30 2021 | CHRS | Coherus BioScience ... | Stilwell McDavid | Chief Financial Off ... | Grant | A | 0.00 | 20,000 | 0 | 30,000 | 10 K to 30 K (+200.00 %) |
Apr 30 2021 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Grant | A | 0.00 | 20,000 | 0 | 73,386 | 53.4 K to 73.4 K (+37.46 %) |
Mar 11 2021 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Option Exercise | M | 10.05 | 57,812 | 581,011 | 17,188 | |
Mar 11 2021 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Option Exercise | M | 9.30 | 20,312 | 188,902 | 4,688 | |
Mar 11 2021 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Option Exercise | M | 2.08 | 24,356 | 50,753 | 0 | |
Mar 11 2021 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Sell | S | 16.25 | 114,240 | 1,856,263 | 53,386 | 167.6 K to 53.4 K (-68.15 %) |
Mar 11 2021 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Buy | M | 10.05 | 57,812 | 581,011 | 167,626 | 109.8 K to 167.6 K (+52.65 %) |
Mar 11 2021 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Buy | M | 9.30 | 20,312 | 188,902 | 109,814 | 89.5 K to 109.8 K (+22.69 %) |
Mar 11 2021 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Buy | M | 2.08 | 24,356 | 50,753 | 89,502 | 65.1 K to 89.5 K (+37.39 %) |
Mar 09 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 9.30 | 20,312 | 188,902 | 4,688 | |
Mar 09 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 15.46 | 6,337 | 97,970 | 53,402 | 59.7 K to 53.4 K (-10.61 %) |
Mar 09 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 15.46 | 20,312 | 314,095 | 59,739 | 80.1 K to 59.7 K (-25.37 %) |
Mar 09 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 9.30 | 20,312 | 188,902 | 80,051 | 59.7 K to 80.1 K (+34.00 %) |
Feb 19 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,488 | 6,221 | 0 | |
Feb 19 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 17.45 | 2,488 | 43,418 | 59,739 | 62.2 K to 59.7 K (-4.00 %) |
Feb 19 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,488 | 6,221 | 62,227 | 59.7 K to 62.2 K (+4.16 %) |
Feb 03 2021 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Option Exercise | A | 17.60 | 50,000 | 880,000 | 50,000 | |
Feb 03 2021 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Option Exercise | A | 17.60 | 125,000 | 2,200,000 | 125,000 | |
Feb 03 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 7,402 | 74,390 | 54,167 | |
Feb 03 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 21.55 | 7,402 | 159,513 | 61,295 | 68.7 K to 61.3 K (-10.77 %) |
Feb 03 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 7,402 | 74,390 | 68,697 | 61.3 K to 68.7 K (+12.08 %) |
Jan 27 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 40,000 | 402,000 | 61,569 | |
Jan 27 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.00 | 6,144 | 116,736 | 61,295 | 67.4 K to 61.3 K (-9.11 %) |
Jan 27 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.10 | 40,000 | 804,000 | 67,439 | 107.4 K to 67.4 K (-37.23 %) |
Jan 27 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 40,000 | 402,000 | 107,439 | 67.4 K to 107.4 K (+59.31 %) |
Jan 26 2021 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Option Exercise | A | 18.33 | 500,000 | 9,165,000 | 500,000 | |
Jan 21 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 2,488 | |
Jan 21 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 17.94 | 2,500 | 44,852 | 59,739 | 62.2 K to 59.7 K (-4.02 %) |
Jan 21 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 62,239 | 59.7 K to 62.2 K (+4.18 %) |
Jan 13 2021 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Option Exercise | A | 17.58 | 20,000 | 351,600 | 20,000 | |
Jan 13 2021 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 17.58 | 20,000 | 351,600 | 20,000 | |
Jan 13 2021 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | A | 17.58 | 20,000 | 351,600 | 20,000 | |
Jan 13 2021 | CHRS | Coherus BioScience ... | TZOUMAKAS KIMBERLY JO | Director | Option Exercise | A | 17.58 | 20,000 | 351,600 | 20,000 | |
Jan 13 2021 | CHRS | Coherus BioScience ... | NUSSBAUM SAMUEL R MD | Director | Option Exercise | A | 17.58 | 20,000 | 351,600 | 20,000 | |
Jan 13 2021 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 17.58 | 20,000 | 351,600 | 20,000 | |
Jan 13 2021 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Option Exercise | A | 17.58 | 62,500 | 1,098,750 | 62,500 | |
Jan 13 2021 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Grant | A | 0.00 | 31,250 | 0 | 65,146 | 33.9 K to 65.1 K (+92.19 %) |
Jan 13 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 17.58 | 62,500 | 1,098,750 | 62,500 | |
Jan 13 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Grant | A | 0.00 | 31,250 | 0 | 67,439 | 36.2 K to 67.4 K (+86.35 %) |
Jan 13 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | A | 17.58 | 62,500 | 1,098,750 | 62,500 | |
Jan 13 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Grant | A | 0.00 | 31,250 | 0 | 59,739 | 28.5 K to 59.7 K (+109.69 %) |
Jan 12 2021 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Payment of Exercise | F | 18.18 | 4,080 | 74,174 | 33,896 | 38 K to 33.9 K (-10.74 %) |
Jan 12 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Payment of Exercise | F | 18.18 | 4,080 | 74,174 | 36,189 | 40.3 K to 36.2 K (-10.13 %) |
Jan 12 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Payment of Exercise | F | 18.18 | 4,080 | 74,174 | 28,489 | 32.6 K to 28.5 K (-12.53 %) |
Jan 12 2021 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Payment of Exercise | F | 18.18 | 4,080 | 74,174 | 28,489 | 32.6 K to 28.5 K (-12.53 %) |
Jan 07 2021 | CHRS | Coherus BioScience ... | STOLPER MARK | Director | Option Exercise | A | 16.85 | 40,000 | 674,000 | 40,000 | |
Jan 07 2021 | CHRS | Coherus BioScience ... | MENDELSON ALAN C | Director | Option Exercise | A | 16.85 | 40,000 | 674,000 | 40,000 | |
Dec 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 4,988 | |
Dec 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 17.51 | 2,500 | 43,780 | 32,569 | 35.1 K to 32.6 K (-7.13 %) |
Dec 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 35,069 | 32.6 K to 35.1 K (+7.68 %) |
Dec 11 2020 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Option Exercise | M | 2.08 | 17,626 | 36,729 | 24,356 | |
Dec 11 2020 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Option Exercise | M | 2.08 | 30,000 | 62,514 | 41,982 | |
Dec 11 2020 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Sell | S | 18.05 | 17,626 | 318,066 | 36,673 | 54.3 K to 36.7 K (-32.46 %) |
Dec 11 2020 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Buy | M | 2.08 | 17,626 | 36,729 | 54,299 | 36.7 K to 54.3 K (+48.06 %) |
Dec 11 2020 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Sell | S | 18.24 | 49,512 | 903,084 | 36,673 | 86.2 K to 36.7 K (-57.45 %) |
Dec 11 2020 | CHRS | Coherus BioScience ... | Vexler Vladimir | Chief Scientific Of ... | Buy | M | 2.08 | 30,000 | 62,514 | 86,185 | 56.2 K to 86.2 K (+53.40 %) |
Dec 09 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 12.70 | 5,791 | 73,546 | 0 | |
Dec 09 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 12.37 | 3,000 | 37,110 | 123,000 | |
Dec 09 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 18.42 | 8,791 | 161,896 | 32,569 | 41.4 K to 32.6 K (-21.25 %) |
Dec 09 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 12.70 | 5,791 | 73,546 | 41,360 | 35.6 K to 41.4 K (+16.28 %) |
Dec 09 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 12.37 | 3,000 | 37,110 | 35,569 | 32.6 K to 35.6 K (+9.21 %) |
Dec 07 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 12.70 | 16,709 | 212,204 | 5,791 | |
Dec 07 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 16.75 | 32,291 | 540,874 | 17,709 | |
Dec 07 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 17.73 | 13,020 | 230,845 | 49,480 | |
Dec 07 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 17.17 | 36,736 | 630,757 | 0 | |
Dec 07 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 18.85 | 49,000 | 923,694 | 32,569 | 81.6 K to 32.6 K (-60.07 %) |
Dec 07 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 12.70 | 16,709 | 212,204 | 81,569 | 64.9 K to 81.6 K (+25.76 %) |
Dec 07 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 16.75 | 32,291 | 540,874 | 64,860 | 32.6 K to 64.9 K (+99.15 %) |
Dec 07 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 18.67 | 49,756 | 929,079 | 32,569 | 82.3 K to 32.6 K (-60.44 %) |
Dec 07 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 17.73 | 13,020 | 230,845 | 82,325 | 69.3 K to 82.3 K (+18.79 %) |
Dec 07 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 17.17 | 36,736 | 630,757 | 69,305 | 32.6 K to 69.3 K (+112.79 %) |
Nov 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 12.70 | 4,283 | 54,394 | 22,500 | |
Nov 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 7,488 | |
Nov 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 18.00 | 4,283 | 77,094 | 32,569 | 36.9 K to 32.6 K (-11.62 %) |
Nov 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 12.70 | 4,283 | 54,394 | 36,852 | 32.6 K to 36.9 K (+13.15 %) |
Nov 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 17.68 | 3,567 | 63,054 | 32,569 | 36.1 K to 32.6 K (-9.87 %) |
Nov 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 17.68 | 12,420 | 219,619 | 36,136 | 48.6 K to 36.1 K (-25.58 %) |
Nov 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 17.50 | 2,500 | 43,744 | 48,556 | 51.1 K to 48.6 K (-4.90 %) |
Nov 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 51,056 | 48.6 K to 51.1 K (+5.15 %) |
Nov 19 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 13.50 | 1,500 | 20,250 | 110,241 | |
Nov 19 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 13.50 | 1,500 | 20,250 | 40,269 | 38.8 K to 40.3 K (+3.87 %) |
Nov 19 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 17.49 | 1,995 | 34,896 | 38,769 | 40.8 K to 38.8 K (-4.89 %) |
Oct 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 12.70 | 717 | 9,106 | 26,783 | |
Oct 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 9,988 | |
Oct 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 17.89 | 3,217 | 57,556 | 48,556 | 51.8 K to 48.6 K (-6.21 %) |
Oct 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 12.70 | 717 | 9,106 | 51,773 | 51.1 K to 51.8 K (+1.40 %) |
Oct 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 51,056 | 48.6 K to 51.1 K (+5.15 %) |
Oct 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 213,546 | 0 | 434,555 | 221 K to 434.6 K (+96.62 %) |
Oct 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | J | 0.00 | 950,000 | 0 | 0 | 950 K to 0 (-100.00 %) |
Oct 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 213,546 | 0 | 434,555 | 221 K to 434.6 K (+96.62 %) |
Oct 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | J | 0.00 | 950,000 | 0 | 0 | 950 K to 0 (-100.00 %) |
Sep 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 12.70 | 2,500 | 31,750 | 27,500 | |
Sep 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 12,488 | |
Sep 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 18.84 | 5,000 | 94,216 | 48,556 | 53.6 K to 48.6 K (-9.34 %) |
Sep 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 12.70 | 2,500 | 31,750 | 53,556 | 51.1 K to 53.6 K (+4.90 %) |
Sep 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 51,056 | 48.6 K to 51.1 K (+5.15 %) |
Sep 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 221,009 | 0 | 221,009 | 0 to 221 K |
Sep 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | J | 0.00 | 983,221 | 0 | 950,000 | 1.9 M to 950 K (-50.86 %) |
Aug 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 12.70 | 2,500 | 31,750 | 30,000 | |
Aug 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 14,988 | |
Aug 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 19.37 | 5,000 | 96,851 | 48,556 | 53.6 K to 48.6 K (-9.34 %) |
Aug 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 12.70 | 2,500 | 31,750 | 53,556 | 51.1 K to 53.6 K (+4.90 %) |
Aug 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 51,056 | 48.6 K to 51.1 K (+5.15 %) |
Aug 03 2020 | CHRS | Coherus BioScience ... | TZOUMAKAS KIMBERLY JO | Director | Option Exercise | A | 18.15 | 40,000 | 726,000 | 40,000 | |
Jul 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 12.70 | 12,500 | 158,750 | 32,500 | |
Jul 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 17,488 | |
Jul 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 18.25 | 15,000 | 273,687 | 48,556 | 63.6 K to 48.6 K (-23.60 %) |
Jul 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 12.70 | 12,500 | 158,750 | 63,556 | 51.1 K to 63.6 K (+24.48 %) |
Jul 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 51,056 | 48.6 K to 51.1 K (+5.15 %) |
Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | M | 12.37 | 20,000 | 247,400 | 0 | |
Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | M | 10.05 | 20,000 | 201,000 | 0 | |
Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | M | 2.50 | 14,997 | 37,500 | 0 | |
Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Sell | S | 17.58 | 54,997 | 966,759 | 0 | 55 K to 0 (-100.00 %) |
Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Buy | M | 12.37 | 20,000 | 247,400 | 54,997 | 35 K to 55 K (+57.15 %) |
Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Buy | M | 10.05 | 20,000 | 201,000 | 34,997 | 15 K to 35 K (+133.36 %) |
Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Buy | M | 2.50 | 14,997 | 37,500 | 14,997 | 0 to 15 K |
Jun 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 19,988 | |
Jun 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 17.22 | 2,500 | 43,050 | 48,556 | 51.1 K to 48.6 K (-4.90 %) |
Jun 19 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 51,056 | 48.6 K to 51.1 K (+5.15 %) |
Jun 19 2020 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Sell | S | 17.15 | 200,000 | 3,430,020 | 0 | 200 K to 0 (-100.00 %) |
May 20 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 22,488 | |
May 20 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 17.17 | 2,500 | 42,925 | 48,556 | 51.1 K to 48.6 K (-4.90 %) |
May 20 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 51,056 | 48.6 K to 51.1 K (+5.15 %) |
May 20 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 17.17 | 593 | 10,182 | 48,556 | 49.1 K to 48.6 K (-1.21 %) |
Apr 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 5,000 | 12,503 | 24,988 | |
Apr 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 17.00 | 5,150 | 87,550 | 47,846 | 53 K to 47.8 K (-9.72 %) |
Apr 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 15.57 | 5,000 | 77,850 | 52,996 | 58 K to 53 K (-8.62 %) |
Apr 21 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 5,000 | 12,503 | 57,996 | 53 K to 58 K (+9.43 %) |
Mar 05 2020 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Sell | S | 20.89 | 4,222 | 88,215 | 200,000 | 204.2 K to 200 K (-2.07 %) |
Mar 05 2020 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Sell | S | 20.09 | 113,844 | 2,287,194 | 204,222 | 318.1 K to 204.2 K (-35.79 %) |
Feb 21 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 3,159 | 31,748 | 101,569 | |
Feb 21 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 22.33 | 3,159 | 70,552 | 46,841 | 50 K to 46.8 K (-6.32 %) |
Feb 21 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 3,159 | 31,748 | 50,000 | 46.8 K to 50 K (+6.74 %) |
Feb 20 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 12.70 | 2,500 | 31,750 | 45,000 | |
Feb 20 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 29,988 | |
Feb 20 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 21.64 | 5,000 | 108,190 | 52,996 | 58 K to 53 K (-8.62 %) |
Feb 20 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 21.64 | 2,500 | 54,100 | 57,996 | 60.5 K to 58 K (-4.13 %) |
Feb 20 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 12.70 | 2,500 | 31,750 | 60,496 | 58 K to 60.5 K (+4.31 %) |
Feb 20 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 21.64 | 2,500 | 54,100 | 57,996 | 60.5 K to 58 K (-4.13 %) |
Feb 20 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 60,496 | 58 K to 60.5 K (+4.31 %) |
Jan 22 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 12.70 | 2,500 | 31,750 | 47,500 | |
Jan 22 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Option Exercise | M | 2.50 | 2,500 | 6,251 | 32,488 | |
Jan 22 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 19.69 | 2,500 | 49,213 | 57,996 | 60.5 K to 58 K (-4.13 %) |
Jan 22 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 12.70 | 2,500 | 31,750 | 60,496 | 58 K to 60.5 K (+4.31 %) |
Jan 22 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 19.56 | 5,000 | 97,796 | 57,996 | 63 K to 58 K (-7.94 %) |
Jan 22 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Sell | S | 19.57 | 2,500 | 48,921 | 62,996 | 65.5 K to 63 K (-3.82 %) |
Jan 22 2020 | CHRS | Coherus BioScience ... | Anicetti Vincent R | Chief Operating Off ... | Buy | M | 2.50 | 2,500 | 6,251 | 65,496 | 63 K to 65.5 K (+3.97 %) |
Jan 17 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 6,318 | 63,496 | 104,728 |